ストックスクリーナーアプリを入手
19.18
2.46%
0.46
アフターアワーズ：
19.00
-0.18
-0.94%
前日終値:
$18.72
開ける：
$18.97
24時間の取引高:
285.92K
Relative Volume:
0.48
時価総額：
$845.70M
収益：
$720.53M
当期純損益:
$79.23M
株価収益率:
11.52
EPS:
1.6648
ネットキャッシュフロー:
$132.94M
1週間 パフォーマンス:
-2.29%
1か月 パフォーマンス:
-11.94%
6か月 パフォーマンス:
-26.93%
1年 パフォーマンス:
-14.26%
1日の値動き範囲:
$18.96
$19.31
1週間の範囲:
$18.50
$19.95
52週間の値動き範囲:
$16.64
$31.26
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
名前
Amphastar Pharmaceuticals Inc
セクター
電話
909-980-9484
住所
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Compare AMPH vs TAK, HLN, TEVA, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
19.18 | 825.42M | 720.53M | 79.23M | 132.94M | 1.6648 |
TAK
Takeda Pharmaceutical Co Adr
|
17.44 | 55.06B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.94 | 43.07B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.08 | 35.88B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
76.92 | 31.59B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
527.94 | 26.32B | 3.17B | 1.29B | 1.01B | 27.09 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-21 | ダウングレード | Jefferies | Buy → Hold |
| 2025-12-09 | 開始されました | Barclays | Equal Weight |
| 2025-08-12 | アップグレード | Needham | Hold → Buy |
| 2025-05-12 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2025-02-04 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2024-11-22 | 開始されました | Wells Fargo | Equal Weight |
| 2024-03-05 | 開始されました | JP Morgan | Overweight |
| 2023-11-17 | 開始されました | BofA Securities | Neutral |
| 2023-07-25 | 再開されました | Jefferies | Buy |
| 2022-10-21 | 再開されました | Jefferies | Buy |
| 2022-07-29 | 開始されました | CapitalOne | Overweight |
| 2022-01-07 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-01-08 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-10-05 | アップグレード | Northland Capital | Market Perform → Outperform |
| 2020-05-01 | 開始されました | Northland Capital | Outperform |
| 2019-03-13 | ダウングレード | Needham | Buy → Hold |
| 2019-03-13 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2018-08-10 | 繰り返されました | Needham | Buy |
| 2018-03-13 | 繰り返されました | Needham | Buy |
| 2017-12-01 | 繰り返されました | Needham | Buy |
| 2017-11-09 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2017-09-27 | 繰り返されました | Needham | Buy |
| 2017-03-14 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2016-08-09 | 繰り返されました | Needham | Buy |
| 2016-05-10 | 繰り返されました | Needham | Buy |
| 2016-02-19 | 開始されました | Wells Fargo | Outperform |
| 2015-06-19 | 繰り返されました | Needham | Buy |
| 2015-06-03 | 開始されました | Raymond James | Strong Buy |
| 2014-07-21 | 開始されました | Needham | Buy |
すべてを表示
Amphastar Pharmaceuticals Inc (AMPH) 最新ニュース
Rice Hall James & Associates LLC Increases Position in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharmaceuticals Inc (AMPH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Amphastar Pharmaceuticals Inc (AMPH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TradingKey - TradingKey
Amphastar Pharmaceuticals Inc - TradingKey
AMPH|Amphastar Pharmaceuticals Inc|Price:18.720|Chg%:-0.150 - TradingKey
Amphastar Pharmaceuticals, Inc. $AMPH Shares Sold by Epoch Investment Partners Inc. - MarketBeat
Amphastar Pharmaceuticals Inc (AMPH) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Forecasts - Yahoo! Finance Canada
Amphastar Pharmaceuticals Inc (AMPH) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Amphastar Pharmaceuticals Inc (AMPH) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Amphastar Pharmaceuticals Inc (AMPH) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
Amphastar Pharmaceuticals, Inc. (AMPH) stock price, news, quote and history - Yahoo Finance Australia
Amphastar Pharmaceuticals Inc (AMPH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
AMPH5896384 Bond Profile — Key Metrics - TradingView
AMPH5896384 Bond Coupon Profile — Rate & Payments - TradingView
Amphastar Pharmaceuticals (NASDAQ:AMPH) Upgraded by Zacks Research to "Hold" Rating - MarketBeat
Quantedge Capital Pte Ltd Sells 78,200 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
US3209RAB9 Bond Coupon Profile — Rate & Payments - TradingView
US3209RAB9 Bond Profile — Key Metrics - TradingView
Amphastar Pharmaceuticals, Inc. (AMPH): Investor Outlook and Growth Potential with 12% Upside - DirectorsTalk Interviews
Amphastar Pharmaceuticals (NASDAQ:AMPH) Screens as a High-Quality Stock with Deep Value Appeal - ChartMill
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Given Average Recommendation of "Reduce" by Brokerages - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Share Price Crosses Below 50 Day Moving AverageShould You Sell? - MarketBeat
Dimensional Fund Advisors stake in Amphastar Pharmaceuticals (AMPH) hits 5.2% - Stock Titan
Form 4 Amphastar P For: 13 July By Investing.com - Investing.com Canada
Amphastar (AMPH) director awarded 7,886 RSUs and 16,646 options at $19.02 - Stock Titan
Amphastar Pharmaceuticals (AMPH) director reports initial insider ownership - Stock Titan
Amphastar (NASDAQ: AMPH) boosts board to 11, appoints Anthony Pierce - Stock Titan
Enterprise value to EBITDA forward of Amphastar Pharmaceuticals, Inc. – DUS:29A - TradingView
Amphastar unit gets FDA warning letter over manufacturing violations - MSN
Amphastar Pharmaceuticals, Inc. Files Form 8-K With SEC – Key Company Details, Contact Info, and Stock Listing on NASDAQ – Minichart - Minichart
Amphastar Unit Receives US FDA Warning Letter on Violations at California Facility - marketscreener.com
Amphastar stock slips on FDA warning letter (AMPH:NASDAQ) - Seeking Alpha
Amphastar Pharmaceuticals subsidiary receives FDA warning letter over CGMP issues at California facility - TradingView
FDA Warning Letter targets Amphastar (NASDAQ: AMPH) IMS manufacturing facility - Stock Titan
Price to earnings forward of Amphastar Pharmaceuticals, Inc. – NASDAQ:AMPH - TradingView
Amphastar Pharmaceuticals Inc. (AMPH) Q1 2026 Earnings: Significant EPS Miss Amidst Operational ChallengesForward EPS Estimate - dars.gov.et
Enterprise value to revenue forward of Amphastar Pharmaceuticals, Inc. – NASDAQ:AMPH - TradingView
Crude Oil Gains 2%; Comcast Shares Spike Higher - Sahm
Amphastar Pharmaceuticals, Inc.(NasdaqGS:AMPH) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Enterprise value to EBIT forward of Amphastar Pharmaceuticals, Inc. – NASDAQ:AMPH - TradingView
Amphastar Pharmaceuticals, Inc.(NasdaqGS:AMPH) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Amphastar Pharmaceuticals, Inc. Stock 12‑Month Price Target Cut to $22, Implies 1% Upside - TradingView
AMPH Downgraded by B of A Securities -- Price Target Lowered to $20 - GuruFocus
BofA cuts Amphastar stock rating on limited growth visibility By Investing.com - Investing.com Canada
Amphastar Pharmaceuticals, Inc.(NasdaqGS:AMPH) dropped from Russell 2000 Growth Benchmark - marketscreener.com
BofA Securities Downgrades Amphastar Pharmaceuticals(AMPH.US) to Sell Rating, Cuts Target Price to $20 - Moomoo
This Liquidia Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Benzinga
Amphastar Pharmaceuticals, Inc.(NasdaqGS:AMPH) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Amphastar Pharmaceuticals Inc (AMPH) 財務データ
収益
当期純利益
現金流量
EPS
Amphastar Pharmaceuticals Inc (AMPH) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Zhou Rong | SENIOR EVP, PRODUCTION CENTER |
Dec 17 '25 |
Sale |
26.20 |
9,787 |
256,379 |
138,043 |
| Petersen Floyd F. | Director |
Dec 12 '25 |
Sale |
25.92 |
2,426 |
62,888 |
71,368 |
| Petersen Floyd F. | Director |
Dec 11 '25 |
Sale |
25.69 |
1,737 |
44,620 |
73,794 |
0.30%
2.01%
大文字化:
|
ボリューム (24 時間):